To share insights and knowledge about stability studies, Q1 Scientific is hosting its second annual Stability Studies conference on Wednesday 18th October 2023 at the Killashee Hotel, Kildare.
Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, … Continued
Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that their stability storage business, Q1 Scientific, has opened a new 20,000 sq ft cGMP facility in Belgium, expanding its capacity for environmentally-controlled stability storage services to the pharmaceutical, medical … Continued
Pharmaceutical and medical device companies often rely on external suppliers such as Q1 Scientific for the development and production of various components of their products. To ensure the safety and quality of their products, pharmaceutical companies or medical device companies with combination products often require their suppliers to complete establishment registration with the FDA.
Q1 Scientific, which offers environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries, today announced that Cécile Jacoby has been appointed General Manager at the new Q1 Scientific Belgium facility. With more than 25 years of experience in senior strategic and operations roles across pharmaceutical, vaccine, healthcare and cell therapy … Continued
This year we are again supporting two fantastic Waterford charities, Down Syndrome Ireland Waterford and South Kilkenny branch and the WLR Christmas appeal in aid of St. Vincent de Paul, Waterford.
Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. Q1 Scientific will open a new 20,000 sq ft cGMP facility in Belgium and add an additional 10,000 sq ft at their existing facility in Waterford, Ireland. The … Continued
Are you joining us at stability studies 2022? This year, we are looking forward to our first ever Stability Studies conference with a full line-up of pharmaceutical industry experts. Joining us at the conference as a guest speaker is Ken O’Shea, Founder and Managing Director of Qbd Pharma Solutions and Co-founder and CTO of new … Continued
This year, we are excited to introduce our first ever Stability Studies conference. Join us at the Killashee Hotel, Naas on Thursday 13th October 2022 to hear experts from the pharmaceutical industry share their tips on evaluating and managing stability studies.
Cambrex, a leading global contract development and manufacturing organisation (CDMO) providing drug substance, drug product, and analytical services across the entire drug life cycle, today announced the acquisition of Q1 Scientific – a leading provider of environmentally-controlled cGMP stability storage services for the pharmaceutical, medical device and life science industries, strategically located in Waterford, Ireland. … Continued